menu
    • menu

    Company profile for Agios Pharmaceuticals

    NEW Drugs in Dev: 12
    Coral

    Virtual Booth

    Contact Supplier

    China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At Agios, our culture and values – which form the foundation of our company and differentiate us – are embodied in the Greek word Arete, the ancient ideal of excellence and fulfillment of one’s potential. Arete has several meanings, and each is applicable to our company. It is often used to describe virtue, to characterize someone as a “good person.” Our company comprises good people who are striving to achieve a vir...
    At Agios, our culture and values – which form the foundation of our company and differentiate us – are embodied in the Greek word Arete, the ancient ideal of excellence and fulfillment of one’s potential. Arete has several meanings, and each is applicable to our company. It is often used to describe virtue, to characterize someone as a “good person.” Our company comprises good people who are striving to achieve a virtuous goal. It also connotes a sense of driving for excellence, which speaks to how far we can push ourselves and reflects our focus on achieving “the other side of possible.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Agios PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    88 Sidney Street Cambridge, MA 02139-4169
    Telephone
    Telephone
    617-649-8600
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.agios.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/agios/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/agiospharma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Agios Licenses Cevidoplenib To Oscotec For Global Development
    Agios Licenses Cevidoplenib To Oscotec For Global Development

    01 Jun 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/06/01/3304100/31990/en/agios-enters-exclusive-global-license-agreement-with-oscotec-to-develop-and-commercialize-next-generation-syk-inhibitor-cevidoplenib.html

    GLOBENEWSWIRE
    01 Jun 2026
    Share Share
    Agios Updates Ph 2b Trial of Tebapivat in Low-Risk MDS Syndrome
    Agios Updates Ph 2b Trial of Tebapivat in Low-Risk MDS Syndrome

    29 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/29/3303496/31990/en/agios-provides-update-on-phase-2b-trial-of-tebapivat-in-lower-risk-myelodysplastic-syndromes.html

    GLOBENEWSWIRE
    29 May 2026
    Share Share
    Agios Scraps Blood Cancer Drug Program After Study Miss
    Agios Scraps Blood Cancer Drug Program After Study Miss

    29 May 2026

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/agios-scraps-blood-cancer-drug-program-after-study-miss-2026-05-29/

    REUTERS
    29 May 2026
    Share Share
    Agios'Pyrukynd Approved in EU for Adults with Thalassemia
    Agios'Pyrukynd Approved in EU for Adults with Thalassemia

    22 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/22/3300143/31990/en/agios-pyrukynd-mitapivat-approved-in-the-european-union-for-adults-with-thalassemia.html

    GLOBENEWSWIRE
    22 May 2026
    Share Share
    Agios Unveils Mitapivat Data for Rare Anemias at EHA 2026
    Agios Unveils Mitapivat Data for Rare Anemias at EHA 2026

    12 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/12/3292999/31990/en/agios-to-present-new-data-at-eha-2026-reinforcing-the-significant-therapeutic-impact-of-mitapivat-across-multiple-rare-hemolytic-anemias.html

    GLOBENEWSWIRE
    12 May 2026
    Share Share
    Agios Files sNDA for Accelerated Approval of Mitapivat in SCD
    Agios Files sNDA for Accelerated Approval of Mitapivat in SCD

    12 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/12/3293011/31990/en/agios-submits-snda-to-fda-for-u-s-accelerated-approval-of-mitapivat-in-sickle-cell-disease.html

    GLOBENEWSWIRE
    12 May 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search